TheWookly
  • Home
  • News
  • Politics
  • Business
  • Culture
  • Opinion
  • Lifestyle
No Result
View All Result
TheWookly
Home Covid-19

When Will We Know We Need A Covid-19 Booster? More Research Needed

Sandra Williams by Sandra Williams
August 6, 2021
in Covid-19, Top News
0
When Will We Know We Need A Covid-19 Booster? More Research Needed
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As Delta Variant is on a full surge and threatens coronavirus pandemic progress, few highly vaccinated countries are providing booster doses of the coronavirus vaccines to citizens. As per the reports of Associated Press, Israel started administering third doses of the Pfizer-BioNTech vaccine to people with more than 60 years of age who are till date fully vaccinated.’

On the other hand, as per Reuters, Germany also plans to begin the booster drive in September to older people with weakened immune systems.  The UK will also start offering the booster d vaccine from next month. However, United States has to hold Covid-19 boosters fully but is now going in this direction. Last month, the CDC (Centres for Disease Control and Prevention) and the FDA (Food and Drug Administration) alleged ‘Fully vaccinated Americans do not need a booster shot at present.’  However, according to agencies, they are continuing to screen the scientist data to determine if and when the booster dose might be required.

Related posts

Matt Bomer's

Matt Bomer’s Bio, Childhood, Marriage, Height, Age, Weight, Social Media, And More

March 30, 2022
chris rock

Chris Rock American Comedian Bio,Career,Marrige,Net Worth,Height,Weight,Social Media

March 30, 2022

When Will We Know We Need A Covid-19 Booster? More Research Needed

On the other hand, Biden government officials are warming to the chance that older adults and people with a weak immune system who are already fully vaccinated with two doses might need a third booster dose. According to New York Times, on the other side, Dr. Amanda Cohn from CDC said ‘agencies actively seek ways’ to offer certain age groups access to booster vaccine doses.

Now FDA   would amend the vaccine’s current EUA, i.e., Emergency use authorization to permit the booster dose to be given. Another possibility can be that full FDA approval which can let doctors recommend a booster dose ‘off label’. As per the Times reports, the FDA will decide regarding the full approval of the Pfizer-BioTech vaccine by coming September. Reports suggest the necessity of boosters and vaccinating children under 12 years of age, if the FDA also approves booster doses for certain groups, the US government will increase its vaccine supply.

When Will We Know We Need A Covid-19 Booster? More Research Needed

Is there a need for Covid-19 boosters?

Though few countries started booster doses, data regarding the need of Covid-19 boosters is still limited for the general public. However, booster doses offer many clear benefits, especially for those with weakened immune systems like cancer patients, organ transplant recipients, or adults with chronic medical conditions. Also, CDC warned on its website that these people might not generate to robust their immune system even after full vaccination.

An oncologist at the University of Pennsylvania, Dr. Ezekiel J.Emanuel, said, ‘we have to give a booster to immunocompromised people and others too who are more prone. I think that is where we are going to start.’ For the left overpopulation, the vaccine protection is enough for several months even if they face to face Delta variant. As per the preprint that was released the prior week, data from Pfizer’s ongoing trials clarifies that the efficacy of the vaccine against symptomatic cases dropped from 96 percent to 83 percent in the time gap of six months after vaccination.

More than half of the American population has now received the Covid-19 vaccination i.e., BioNTech’s vaccine doses. The efficacy is more than 80 percent and which is still high. The Pfizer study also revealed that the vaccine continues to provide strong protection against the virus with 96 percent efficacy during the six months following vaccination.

Vaccines hold up well against the Delta variant – what studies say

There are few studies that show certain vaccines hold well against the Delta variant though they showed up mixed outcomes. However, current figures from Israel, where vaccination is done with about 60 percent of the population, noted a larger drop in protection. As Bloomberg reported, data came from the Israel Ministry of Health, and that showed that amid 20th June to 17th June, the Pfizer BioTech vaccine was just 39 percent effective against Delta variant infection, and this low protection shocked many.

As per experts, the requirement of boosters would depend on how well the vaccines still protect people, and it will require ongoing world monitoring of vaccine effectiveness. However, vaccine makers are considering the benefits of booster doses by focusing on variants of concern at present.

Related

Tags: Featured

POPULAR NEWS

  • Torroband-review

    Torroband Reviews – For Total Body Workout Solution?

    0 shares
    Share 0 Tweet 0
  • 10 Meal Prep Ideas for Vegans

    0 shares
    Share 0 Tweet 0
  • Master Needs Some Help! Release Date

    0 shares
    Share 0 Tweet 0
  • Q2 2022 HCA Healthcare, Inc. Earnings Forecast for (NYSE:HCA) released by SVB Leerink

    0 shares
    Share 0 Tweet 0
  • B. Riley Financial: Capital markets activities fuel long-term revenue growth (NASDAQ:RILY)

    0 shares
    Share 0 Tweet 0
Facebook Twitter Youtube Pinterest

Useful Links

  • About
  • Contact
  • Advertise
  • Privacy Policy
  • Disclaimer
  • Terms and Conditions

About Us

Let it be entertainment, business, politics, or tech, The Wookly provides you with the latest news about everything happening all around the globe.

Copyright © 2022 TheWookly. All Rights Reserved

No Result
View All Result
  • Home
  • Politics
  • News
  • Business
  • Culture
  • National
  • Sports
  • Lifestyle
  • Travel
  • Opinion

Copyright © 2022 TheWookly. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
SAVE & ACCEPT